Decision Support for Solubilization is now available in ZoomLab™
If you are working with poorly water-soluble APIs and wondering about effective formulation strategies – this 2.4 version update to ZoomLab™ by BASF is truly revolutionary.
- Calculate Hansen SOL parameters for any APIs
- Discover formulation strategy recommendations
- Search similar drug products
- Predict solubility in lipids
- Explore achievable drug loading schemes
This is literally countless hours of work calculated in seconds… try it, you’ll be amazed!
The “Decision Support for Solubilization” module helps formulators evaluate whether amorphous solid dispersions or lipid-based formulations are suitable dosage forms for your active ingredient.
Poorly soluble drugs for oral administration present unique formulation challenges, particularly during early development. ZoomLab™’s “Decision Support for Solubilization” module helps formulators evaluate whether amorphous solid dispersions or lipid-based formulations are suitable dosage forms for your active ingredient!
ZoomLab™’s “Decision Support for Solubilization” module evaluates several parameters relevant for the structured
development of poorly soluble drugs. Based on user-input experimental and computed properties, guidance on the
following aspects is given:
- Estimated solubility in lipids
- Expected glass-forming ability
- Attainable drug load in solid dispersions
- Suitable formulation type based on classification algorithms
- Formulation examples of similar active ingredients
Based on the recommended formulation type, ZoomLab™ provides the user with further advice on subsequent
formulation development. Find the new “Decision Support for Solubilization” module on ZoomLab™’s homepage with the Solubilization modules.
Register for the new ZoomLab™ webinar: Digitally guiding dosage form and formulation for improved solubility
